Stereotaxis has formed, and continues to build on, critical strategic alliances with leading companies in the medical technology industry and also to build relationships with certain important OEM and specialty software providers. The Company’s collaborations include co-development of new devices and other products, advanced software and hardware integration of imaging modalities, co-marketing and co-selling of devices and coordinated provision of service on a worldwide basis. We are privileged to have formed partnerships with the leading companies in the cardiac cath lab industry and to enjoy the substantial and continuing support that they have provided for commercialization of our technology. We view these relationships as endorsement of the Company’s vision that our technology has the potential to revolutionize the practice of cardiac interventional medicine by providing hospitals and their clinicians with the wherewithal to treat patients more safely, predictably and effectively, to expand procedure volumes, enable more complex cases, standardize procedure times and improve overall efficiency.